Science and innovation are the lifeblood of our company. But we’re doing more than developing medicines that perform well in the lab—we’re elevating the current standard of care to bring greater benefits to our patients.
patients living with conditions that our pipeline aims to treat, from cancer and Alzheimer’s disease to chronic immune-mediated conditions
Bringing Better Solutions to Patients
By investing in groundbreaking technologies and platforms, our goal is to drive innovation within our pipeline and deliver better solutions to patients.
products with potential for new drug or indication approvals by the end of 2020
programs in Phase III under way
scientists working globally to make a difference
A Portfolio of Medicines
We aim to develop innovative therapies for health conditions where there is significant need. Our medicines are approved in individual countries for different uses around the globe.